Presentation The Structural Heart Disease Summit 2018 Pilot Programs to Address Reduced TAVR Access in Underserved Populations and Communities Presenter: Aaron Horne, Jr. June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning Presenter: Mark J. Russo June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency Presenter: Harindra Wijeysundera June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Pi-Cardia Leaflex Aortic Valve Remodeling: Experimental Findings and Early Human Experiences Presenter: Darren Mylotte June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Shockwave Aortic Valve Remodeling: Experimental Findings and Future Clinical Applications Presenter: Eberhard Grube June 21, 2018
Presentation The Structural Heart Disease Summit 2018 New Applications for the V8 Valvuloplasty Balloon Presenter: Wesley R. Pedersen June 21, 2018
Presentation The Structural Heart Disease Summit 2018 The "Family" of TRUE Balloons: Design Characteristics and Clinical Applications Presenter: Susheel K. Kodali June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Improved Temporary Transvenous Pacemakers: The BioTrace Tempo Lead Presenter: Steven J. Yakubov June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Presenter: Michael J. Reardon June 21, 2018
Presentation The Structural Heart Disease Summit 2018 NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk Presenter: Lars Sondergaard June 21, 2018